Brain Awareness Week Webinar: Understanding the Cellular Roots of Alzheimer’s Disease
Wednesday, March 9, 2022
4:00-5:00pm Pacific Time
Alzheimer’s disease is a common form of dementia that affects thining and memory skills. However, despite affecting an estimated 6.2 million adults in the US alone in 2021, its causes are poorly understood and no effective treatments exist to halt or reverse the neuron death caused by the disease. How the disease starts — and what happens in single cells across the brain as the disease progresses — is similarly unknown. Research at the Allen Institute for Brain Science and UW ADRC focus on the types of cells that make up the human brain has applications for understanding what is happening in Alzheimer’s.
At this webinar, learn about the challenges physicians face in treating Alzheimer’s disease, what happens to the brain in patients with this disease, and research on brain cell types. This free webinar is geared towards members of the general public who are interested in learning more about Alzheimer’s disease, brain cell types, and current research in both areas. The presenters will not assume any prior knowledge of neuroscience of Alzheimer’s or cell types. This event is also suitable for students at high school level and above.
Speakers: Kimiko Domoto-Reilly, MD (UW ADRC), Rebecca Hodge, PhD (Allen Institute for Brain Science), Caitlin Latimer, MD, PhD (UW ADRC), Ed Lein, PhD (Allen Institute for Brain Science/UW ADRC), Kyle Travaglini, PhD (Allen Institute for Brain Science). Moderator: Kaitlyn Casimo, PhD (Allen Institute)
Host: This webinar is presented by members of the Alzheimer’s Center at the Allen Institute for Brain Science, an NIH-supported collaboration between the Allen Institute for Brain Science, UW Medicine, and Kaiser Permanente WA Health Research Institute. Its goal is to apply the methods and understanding of cell types developed in part at the Allen Institute for Brain Science to Alzheimer’s disease, particularly in the early stages of the disease and to identifying potential therapy targets.
Introduction: Ed Lein, Ph.D.
Clinical challenges of Alzheimer's disease: Kimiko Domoto-Reilly, M.D.
Neuropathology of Alzheimer's disease: Caitlin Latimer, M.D., Ph.D.
Introduction to cell types in neuroscience: Rebecca Hodge, Ph.D.
Cell types in Alzheimer's disease: Kyle Travaglini, Ph.D.
Q&A: all speakers
Audience members will be invited to submit questions for the speakers at any point in the program.